10x Genomics

US · TXG #1311 by market cap Listed 2019

76.10 -4.56 -5.65%

Live - 5344 symbols - heartbeat 16s ago · 2026-10-08 06:44

Pre-market 73.50 -3.42%

After-hours 76.20 +0.13%

Overnight 75.78 -0.42%

Market cap: 9.92B
P/E (TTM): -128.98
P/B: 12.01
EPS: -0.35
Div yield: 0.00%
52W pos: 71%

Reader sentiment Are you bullish or bearish on TXG?

Anonymous reader poll. Unscientific, not investment advice.

About 10x Genomics

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.

Founded: 2012
CEO: Dr. Serge Saxonov, PhD
Employees: 1,178
Headquarters: Pleasanton, California, United States of America
Fiscal year end: 12-31
Website: 10xgenomics.com

Company profile

Exchange: US
Symbol: TXG
Market-cap rank: #1311
Listing date: 2019-09-12
Market cap: 9.92B
Float cap: 8.99B
Shares out: 130.29M
Float shares: 118.16M

Sectors & themes

Medical Devices ARK Portfolio AI medical concept stocks Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 06:44:45 · For reference only, not investment advice and not tailored to your situation.